This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Under $10 Set to Soar


One under-$10 stock that could be poised for a powerful bounce higher is Exelixis (EXEL), a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. Exelixis is focusing its resources and development efforts on cabozantinib (XL184). This stock has been hit hard by the bears during the last six months, with shares off by 20%.

If you take a look at the chart for Exelixis, you'll notice that this stock was hammered by the sellers during the last few trading sessions, with shares plunging from $6.95 to a recent low of $4.27 a share. That selloff came with monster volume, and during the move shares of EXEL never once flashed a buy signal since it was clearly downtrending.

That said, the stock has now entered oversold territory since its relative strength index reading is trending below 30. Shares of EXEL have also now dropped down near some previous support levels at $4.40 to $4 a share.

>>5 Stocks Insiders Love Right Now

Just this morning, huge upside volume is moving into EXEL with over 31 million shares traded versus its three-month average volume of 1.8 million shares. At last check, EXEL is up 5.2% off that monster upside volume. That huge volume is due to a secondary offering that price 30 million shares at $4.25.

Traders should now look for long-biased trades in EXEL if it can manage to hold a trend above $4.40 to $4 a share with strong upside volume flows. I would consider any upside volume day that registers near or above 1.88 million shares as bullish. If EXEL continues to see buyers step in here and support that price above $4 a share, then we could easily see this stock make a huge bounce. Some upside targets off an oversold bounce are $5.50 to $6 a share.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
JRCC $0.00 0.00%
DRYS $4.01 0.00%
EXEL $4.61 0.00%
NG $6.49 0.00%
ROSG $1.31 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs